Industry experts from Marsh McLennan Agency tackle four pivotal pharmacy benefits topics: managing GLP-1 drug costs, evaluating cash-pay and discount models, developing biosimilar strategies, and mitigating financial risk from high-cost gene therapies. Watch our replay and gain actionable strategies to align cost control with member access and clinical results in this rapidly changing environment.



Related insights

Replay

Webinar: Future proof your organization’s pharmacy benefits

Industry experts from Marsh McLennan Agency tackle four pivotal pharmacy benefits topics: managing GLP-1 drug costs, evaluating cash-pay and discount models, developing biosimilar strategies, and mitigating financial risk from high-cost gene therapies. Watch our replay and gain actionable strategies to align cost control with member access and clinical results ...

Blogs

Construction site pollution: Insurance solutions and practical mitigation tips

Construction sites hide more pollution risk than many owners and contractors realize. Fuel spills, disturbed contaminated soil, legacy building materials, and routine missteps in material handling can lead to costly cleanup, regulatory fines, third‑party claims, and project delays. Taking steps to mitigate those risks—and securing the right insurance—protects budgets, ...

Infographics

Private Equity Practice

Marsh McLennan Agency’s Private Equity Practice partners with private equity firms throughout the investment lifecycle to strengthen decision-making, reduce risk, and enhance portfolio value. Our practice offers a full suite of services across three key phases: pre-close and due diligence, transaction / placement, and risk services. Our goal is to ...

More Insights